7V5N
Crystal structure of Fab fragment of bevacizumab bound to DNA aptamer
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PHOTON FACTORY BEAMLINE BL-17A |
Synchrotron site | Photon Factory |
Beamline | BL-17A |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2018-05-29 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.98 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 42.543, 130.599, 90.244 |
Unit cell angles | 90.00, 103.59, 90.00 |
Refinement procedure
Resolution | 19.710 - 1.700 |
R-factor | 0.17952 |
Rwork | 0.178 |
R-free | 0.21002 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1bj1 |
RMSD bond length | 0.006 |
RMSD bond angle | 1.104 |
Data reduction software | XDS |
Data scaling software | SCALA |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0238) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 20.000 | 1.790 |
High resolution limit [Å] | 1.700 | 1.700 |
Rmerge | 0.048 | 0.511 |
Number of reflections | 104111 | 15208 |
<I/σ(I)> | 12.6 | |
Completeness [%] | 99.3 | |
Redundancy | 3.4 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION | 293 | Sulfate |